Qualitative versus quantitative assessment of cerebrovascular reactivity to acetazolamide using iodine-123-N-isopropyl-p-iodoamphetamine spect in patients with unilateral major cerebral artery occlusive disease

American Journal of Neuroradiology

Volumn 24, Issue 6, 2003, Pages 1090-1095

  Ogasawara, Kuniaki ^a   Okuguchi, Taku ^b   Sasoh, Masayuki ^b   Kobayashi, Masakazu ^b   Yukawa, Hirotsugu ^b   Terasaki, Kazunori ^b   Inoue, Takashi ^b   Ogawa, Akira ^b  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; IOFETAMINE I 123;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HEMISPHERE; HEMODYNAMIC MONITORING; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION PROCESS;

ACETAZOLAMIDE; ADULT; AGED; BLOOD FLOW VELOCITY; BRAIN; CARBONIC ANHYDRASE INHIBITORS; CAROTID STENOSIS; DOMINANCE, CEREBRAL; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; IOFETAMINE; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASCULAR RESISTANCE;

EID: 0038614793     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Burt RW, Witt RM, Cikrit DF, Reddy RV. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology 1992;182:461-466
2. Hoshi H, Ohnishi T, Jinnouchi S, et al. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nucl Med 1994;35:44-50
3. Soricelli A, Postiglione A, Cuocolo A, et al. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease: a comparison with acetazolamide. Stroke 1995; 26:1572-1576
4. Ohnishi T, Yano T, Nakano S, et al. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease. J Nucl Med 1997;38:1463-1467
5. Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol 2001;22:928-936
6. Kim JS, Moon DH, Kim GE, et al. Acetazolamide stress brain-perfusion SPECT predicts the need for carotid shunting during carotid endarterectomy. J Nucl Med 2000;41:1836-1841
7. Marti-Fabregas JA, Catafau AM, Mari C, et al. Cerebral perfusion and haemodynamics measured by SPECT in symptom-free patients with transient ischaemic attack: clinical implications. Eur J Nucl Med 2001;28:1828-1835
8. Kim JH, Lee SJ, Shin T, et al. Correlative assessment of hemodynamic parameters obtained with T2*-weighted perfusion MR imaging and SPECT in symptomatic carotid artery occlusion. AJNR Am J Neuroradiol 2000;21:1450-1456
9. Cao B, Hasegawa Y, Yokota C, et al. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med 1998;39:1348-1353
10. Isaka Y, Nagano K, Narita M, Ashida K, Imaizumi M. High signal intensity on T2-weighted magnetic resonance imaging and cerebral hemodynamic reserve in carotid occlusive disease. Stroke 1997;28:354-357
11. Hwang TL, Saenz A, Farrell JJ, Brannon WL. Brain SPECT with dipyridamole stress to evaluate cerebral blood flow reserve in carotid artery disease. J Nucl Med 1996;37:1595-1599
12. Knapp WH, Dannenberg C, Marschall B, et al. Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function. Eur J Nucl Med 1996;23:878-888
13. Laloux P, Jamart J, Meurisse H, De Coster P, Laterre C. Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup? Stroke 1996;27:425-430
14. 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. Stroke 1996;27:282-289
15. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110-2116
16. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002;33:1857-1862
17. Yokota C, Hasegawa Y, Minematsu K, Yamaguchi T. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998;29:640-644
18. Yonas H, Pindzola RR. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998;29:1742-1744
19. Yonas H, Pindzola RR, Meltzer CC, Sasser H. Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery 1998;42:1005-1012
20. Iida H, Itoh H, Nakazawa M, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 1994;35:2019-2030
21. Iida H, Itoh H, Bloomfield PM, et al. A clinical method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med 1994;21:1072-1084
22. Ogasawara K, Ito H, Sasoh M, et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using iodine-123-IMP autoradiography with SPECT: validation study using oxygen-15-water with PET J Nucl Med 2003;44:520-525.
23. Ogura T, Takikawa S, Saito H, Nakazawa M, Shidahara M, Iida H. Validation and optimization of the use of standardized arterial input function in N-isopropyl-p[123I]iodoamphetamine cerebral blood flow SPECT. Kaku Igaku (Jpn J Nucl Med) 1999;36:879-890
24. Hatazawa J, Iida H, Shimosegawa E, Sato T, Murakami M, Miura Y. Regional cerebral blood flow measurement with iodine-123-IMP autoradiography: normal values, reproducibility and sensitivity to hypoperfusion. J Nucl Med 1997;38:1102-1108
25. Toyoda H, Nishizawa S, Shiozaki T, Ueno M, Konishi J. A simplified double-injection method to quantity cerebral blood flow and vascular reserve using iodine-123 IMP-SPECT. Ann Nucl Med 2002;16:127-135
26. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248
27. Cohen J A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:27-46
28. Yamauchi H, Fukuyama H, Kimura J, Konishi J, Kameyama M. Hemodynamics in internal carotid artery occlusion examined by positron emission tomography. Stroke 1990;21:1400-1406
29. Yamauchi H, Fukuyama H, Nagahama Y, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999;40:1992-1998